Aries Wealth Management Horizon Therapeutics Public LTD CO Transaction History

Aries Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$86.42 - $109.81 $216,050 - $274,525	-2,500 Closed	0 $0
Q4 2021 Jun 06, 2022	SELL	$98.56 - $119.91 $1.48 Million - $1.8 Million	-15,000 Reduced 85.71%	2,500 $269,000
Q4 2021 Jan 18, 2022	BUY	$98.56 - $119.91 $1.48 Million - $1.8 Million	15,000 Added 600.0%	17,500 $1.89 Million
Q1 2021 Apr 20, 2021	BUY	$71.83 - $95.48 $179,575 - $238,700	2,500 New	2,500 $229,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Aries Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Aries Wealth Management with notifications on news.